| Literature DB >> 26514327 |
Patrick Yap1, Leanne Super2, Jinyi Qin3, Trent Burgess1,4, Zdenka Prodanovic5, Caitlin Edwards3, Rosemary Thomas2, Karen Carpenter3, Tiong Yang Tan1,4.
Abstract
Neurofibromatosis type 1 (NF1) is caused by mutations in the tumor suppressor gene NF1. The increased tumor risk in affected individuals is well established, caused by somatic biallelic inactivation of NF1 due to loss of heterozygosity. Pediatric teratoma has not been reported in individuals with NF1 previously. We report a case of congenital teratoma in an infant with a heterozygous maternally inherited pathogenic NF1 mutation (c.[1756_1759delACTA] and p.[Thr586Valfs*18]). We detected a "second hit" in the form of mosaic whole NF1 deletion in the tumor tissue using multiplex ligation-dependent probe amplification, as a proof to support the hypothesis of NF1 involvement in the pathogenesis of teratoma.Entities:
Keywords: NF1; loss of heterozygosity; neurofibromatosis type 1; teratoma
Mesh:
Year: 2015 PMID: 26514327 DOI: 10.1002/pbc.25812
Source DB: PubMed Journal: Pediatr Blood Cancer ISSN: 1545-5009 Impact factor: 3.167